abstract |
The present disclosure provides antibodies and antigen-binding fragments thereof capable of binding a SARS-CoV-2 antigen and, in certain embodiments, neutralizing SARS-CoV-2 infection. Polynucleotides encoding antibodies or antigen-binding fragments, vectors and host cells comprising the polynucleotides, pharmaceutical compositions, and antibodies, antigen-binding fragments, polynucleotides disclosed herein for treating or diagnosing SARS-CoV-2 infection, Methods of using the vectors, host cells, and compositions are also provided. |